Glaxosmithkline

Latest Stories

Timeline of events for diabetes pill Avandia

By ASSOCIATED PRESS - Associated Press

US restricts, EU bans controversial diabetes pill

By MATTHEW PERRONE - Associated Press

FDA keeps diabetes pill with heart risks on market

By ASSOCIATED PRESS - Associated Press

Diabetes drug off market in Europe

By Matthew Perrone - Associated Press

Spiriva as good as Serevent in asthma study

By ALICIA CHANG - Associated Press

FDA warns of brain problem with Glaxo seizure drug

By ASSOCIATED PRESS - Associated Press

FDA issues hold on much-debated Avandia study

By MATTHEW PERRONE and LINDA A. JOHNSON - Associated Press

FDA panel: Diabetes drug should stay on market

By MATTHEW PERRONE - Associated Press

FDA panel votes to keep Avandia

By Matthew Perrone - Associated Press

A pharmacist holds a bottle of Avandia pills at Maximart Pharmacy in Palo Alto, Calif., on Wednesday, June 30, 2010. (AP Photo/Paul Sakuma)

FDA review spotlights heart risk of diabetes pill

By MATTHEW PERRONE - Associated Press